CEACAM5 and cancer: Highly glycosylated carcinoembryonic antigen (CEA), and carbohydrate antigen 19-9 (CA19-9; sialyl Lewis A) are commonly used clinical test indicators, before and after surgery, in several cancer, including CRC.